Idelalisib
Idelalisib Brand Name– ZYDELIG What is Idelalisib Idelalisib is a phosphatidylinositol 3-kinase inhibitor. It is indicated in combination with rituximab for the treatment of relapsed chronic lymphocytic leukemia (CLL) and as a single-agent for the treatment of relapsed B-cell follicular lymphoma (FL) or relapsed small lymphocytic lymphoma in patients who have received at least 2 …
